News
Viamet to Present at the 2016 Mycoses Study Group Education and Research Consortium Conference
Presentation to Highlight Exciting Novel Antifungal Drug Candidate VT-1598
Viamet Pharmaceuticals, Inc. today announced that the company will present at the biennial meeting of the Mycoses Study Group Education and Research Consortium (MSGERC), September 20-23, 2016, at the Asilomar Conference Grounds, Pacific Grove, California, USA. The MSGERC is a non-profit organization comprised of leading infectious disease physicians, educators and researchers committed to supporting evidence-based medicine to benefit patients afflicted with or at risk of invasive fungal infections.